Natural Killer Cell Adoptive Transfer Therapy Exploiting the First Line of Defense Against Cancer

被引:98
作者
Davis, Zachary B. [1 ]
Felices, Martin [1 ]
Verneris, Michael R. [1 ]
Miller, Jeffrey S. [1 ]
机构
[1] Univ Minnesota, Dept Pediat, Blood & Marrow Transplant Program, Minneapolis, MN 55455 USA
关键词
Adoptive transfer therapy; antitumor functions; natural killer (NK) cells; prospective therapeutic enhancements; tumor microenvironment; RELAPSED/REFRACTORY MULTIPLE-MYELOMA; APOPTOSIS-INDUCING LIGAND; KIR ANTIBODY IPH2101; REGULATORY T-CELLS; HUMAN NK CELLS; MHC CLASS-I; TUMOR-CELLS; CYTOMEGALOVIRUS REACTIVATION; MATRIX METALLOPROTEINASES; SURFACE EXPRESSION;
D O I
10.1097/PPO.0000000000000156
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Natural killer (NK) cells constitute an important component of the initial immunological response against transformed cells. However, chronic exposure to the tumor microenvironment can fundamentally alter the ability of NK cells to sufficiently control tumor progression. Thus, the adoptive transfer of healthy, functional NK cells as an interventional therapy has been an area of great interest for improving patient outcomes. Recent developments in the field have provided a better understanding of what makes the NK compartment effective against malignant cells. Moreover, there are now multiple potential sources of NK cell products for infusion as well as techniques to manipulate these cells to enhance their antitumor functions. This review explores the advantages and disadvantages of various sources of NK cells as well as prospective therapeutic enhancements to adoptively transferred NK cells.
引用
收藏
页码:486 / 491
页数:6
相关论文
共 82 条
[1]   Human NK cell education by inhibitory receptors for MHC class I [J].
Anfossi, Nicolas ;
Andre, Pascale ;
Guia, Sophie ;
Falk, Christine S. ;
Roetynck, Sophie ;
Stewart, C. Andrew ;
Breso, Violette ;
Frassati, Coralie ;
Reviron, Denis ;
Middleton, Derek ;
Romagne, Francois ;
Ugolini, Sophie ;
Vivier, Eric .
IMMUNITY, 2006, 25 (02) :331-342
[2]   Clearance of acute myeloid leukemia by haploidentical natural killer cells is improved using IL-2 diphtheria toxin fusion protein [J].
Bachanova, Veronika ;
Cooley, Sarah ;
Defor, Todd E. ;
Verneris, Michael R. ;
Zhang, Bin ;
McKenna, David H. ;
Curtsinger, Julie ;
Panoskaltsis-Mortari, Angela ;
Lewis, Dixie ;
Hippen, Keli ;
McGlave, Philip ;
Weisdorf, Daniel J. ;
Blazar, Bruce R. ;
Miller, Jeffrey S. .
BLOOD, 2014, 123 (25) :3855-3863
[3]  
BARLOZZARI T, 1983, J IMMUNOL, V131, P1024
[4]   Interleukin-2, interleukin-15, and their roles in human natural killer cells [J].
Becknell, B ;
Caligiuri, MA .
ADVANCES IN IMMUNOLOGY, VOL 86, 2005, 86 :209-239
[5]   A Phase I Trial of the Anti-KIR Antibody IPH2101 and Lenalidomide in Patients with Relapsed/Refractory Multiple Myeloma [J].
Benson, Don M., Jr. ;
Cohen, Adam D. ;
Jagannath, Sundar ;
Munshi, Nikhil C. ;
Spitzer, Gary ;
Hofmeister, Craig C. ;
Efebera, Yvonne A. ;
Andre, Pascale ;
Zerbib, Robert ;
Caligiuri, Michael A. .
CLINICAL CANCER RESEARCH, 2015, 21 (18) :4055-4061
[6]   A phase 1 trial of the anti-KIR antibody IPH2101 in patients with relapsed/refractory multiple myeloma [J].
Benson, Don M., Jr. ;
Hofmeister, Craig C. ;
Padmanabhan, Swaminathan ;
Suvannasankha, Attaya ;
Jagannath, Sundar ;
Abonour, Rafat ;
Bakan, Courtney ;
Andre, Pascale ;
Efebera, Yvonne ;
Tiollier, Jerome ;
Caligiuri, Michael A. ;
Farag, Sherif S. .
BLOOD, 2012, 120 (22) :4324-4333
[7]   IPH2101, a novel anti-inhibitory KIR antibody, and lenalidomide combine to enhance the natural killer cell versus multiple myeloma effect [J].
Benson, Don M., Jr. ;
Bakan, Courtney E. ;
Zhang, Shuhong ;
Collins, Shauna M. ;
Liang, Jing ;
Srivastava, Shivani ;
Hofmeister, Craig C. ;
Efebera, Yvonne ;
Andre, Pascale ;
Romagne, Francois ;
Blery, Mathieu ;
Bonnafous, Cecile ;
Zhang, Jianying ;
Clever, David ;
Caligiuri, Michael A. ;
Farag, Sherif S. .
BLOOD, 2011, 118 (24) :6387-6391
[8]   The PD-1/PD-L1 axis modulates the natural killer cell versus multiple myeloma effect: a therapeutic target for CT-011, a novel monoclonal anti-PD-1 antibody [J].
Benson, Don M., Jr. ;
Bakan, Courtney E. ;
Mishra, Anjali ;
Hofmeister, Craig C. ;
Efebera, Yvonne ;
Becknell, Brian ;
Baiocchi, Robert A. ;
Zhang, Jianying ;
Yu, Jianhua ;
Smith, Megan K. ;
Greenfield, Carli N. ;
Porcu, Pierluigi ;
Devine, Steven M. ;
Rotem-Yehudar, Rinat ;
Lozanski, Gerard ;
Byrd, John C. ;
Caligiuri, Michael A. .
BLOOD, 2010, 116 (13) :2286-2294
[9]   DOWN-REGULATION OF FC-GAMMA RECEPTOR IIIA-ALPHA (CD16-II) ON NATURAL-KILLER-CELLS INDUCED BY ANTI-CD16 MAB IS INDEPENDENT OF PROTEIN-TYROSINE KINASES AND PROTEIN-KINASE-C [J].
BORREGO, F ;
LOPEZBELTRAN, A ;
PENA, J ;
SOLANA, R .
CELLULAR IMMUNOLOGY, 1994, 158 (01) :208-217
[10]   Role of spontaneous and interleukin-2-induced natural killer cell activity in the cytotoxicity and rejection of Fas+ and Fas- tumor cells [J].
Bradley, M ;
Zeytun, A ;
Rafi-Janajreh, A ;
Nagarkatti, PS ;
Nagarkatti, M .
BLOOD, 1998, 92 (11) :4248-4255